More than 30 years ago, the St Vincent meeting brought the urgency of taking action ondiabetes to the fore. Through the St Vincent Declaration, it secured the commitment of many European governments.

Since then, much has been achieved, not least through the engagement of PwD, patient and HCP organisations, many other organisations across the diabetes community, and many policy-makers at the national and European level (such as the EU Diabetes Working Group).

With the right care, a person living with diabetes can now lead a long and healthy life, with full realisation of their personal expectations. Ground-breaking research is lookinginto the prevention of T1D, and cell and genetherapies are being considered as alternativesto current treatments. Arti cial Intelligence isalso revolutionising many aspects of diabetes

management such as blood glucose control and insulin delivery and has shown great promise in diagnosing people earlier and improving diabetes education, support and management.

However, much remains to be done. The ‘MEPs Mobilising for Diabetes Blueprint for Action on Diabetes to 2030’ is a guide and represents a renewed commitment to supporting policies and programmes that will help attenthe diabetes curve and reduce costs and inequalities. It also aims to build resilient health systems that are better equipped to care for people living with chronic diseases, including diabetes.

The ultimate goal of this blueprint is to improve the lives of PwD in the short term. Longer-term, the focus must be on eradi- cating the condition altogether.

Full text pdf 15 sidor
www red DiabetologNytt